Publications by authors named "Makoto Ita"

Effect of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidazole-5-carboxamide (FK614), a novel nonthiazolidinedione peroxisome proliferator-activated receptor (PPAR) gamma agonist, on glucose tolerance and insulin resistance in peripheral tissues and in liver using Zucker fatty rats (genetically obese and insulin-resistant) was evaluated and compared to other insulin sensitizers. FK614 (0.32, 1 and 3.

View Article and Find Full Text PDF

Background: Cell transplantation has recently been challenged to improve cardiac function of severe heart failure. Human mesenchymal stem cells (hMSCs) are multipotent cells that can be isolated from adult marrow stroma, but because of their limited life span, it is difficult to study them further. To overcome this problem, we attempted to prolong the life span of hMSCs and investigate whether the hMSCs modified with cell-cycle-associated genes can differentiate into cardiomyocytes in vitro.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the antidiabetic effects of a new compound, FK614, in comparison with existing medications like rosiglitazone and pioglitazone, using diabetic mice models.
  • FK614 demonstrated comparable effectiveness in reducing blood sugar and significantly improved triglyceride levels, particularly in db/db mice, highlighting its strong therapeutic potential.
  • While FK614 activated PPARgamma similar to thiazolidinedione drugs, it showed a lower maximum effect, and toxicity studies indicated it may have a safer profile than rosiglitazone, suggesting FK614 could be a promising candidate for type 2 diabetes treatment.
View Article and Find Full Text PDF

We have previously reported that leukemia inhibitory factor (LIF) gradually increased cardiac L-type Ca2+ channel current (I(CaL)), which peaked at 15 minutes in both adult and neonatal rat cardiomyocytes, and this increase was blocked by the mitogen-activated protein kinase kinase inhibitor PD98059. This study investigated the molecular basis of LIF-induced augmentation of I(CaL) in rodent cardiomyocytes. LIF induced phosphorylation of a serine residue in the alpha(1c) subunit (Ca(v)1.

View Article and Find Full Text PDF

Phase 2 reentry (P2R) is known to be one of the mechanisms of malignant ventricular arrhythmias, especially those associated with Brugada syndrome. However, little is known about the underlying mechanism for P2R. Our aim in this study was to simulate P2R in a mathematical model to enable us to understand its mechanism and identify a potential therapeutic target.

View Article and Find Full Text PDF